Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...

Discover how golden apple snails' eye regeneration offers insights into restoring human vision through genetic understanding and CRISPR technology.

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...

A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.

A Leicester teen is “really well” after being the first to receive a pioneering blood cancer treatment. Alyssa Tapley was ...

In this interview, Dr. Neil Sheppard, director of the Therapeutic Innovation in Natural Killer cells (THINK) lab at the University of Pennsylvania, discusses the challenges involved in developing new ...

A year of new treatments, new technologies, new ways to stay safe during disasters and new insights on the mysteries of the ...

Almost two thirds of patients with T-cell acute lymphoblastic leukaemia involved in a clinical trial of the treatment are now ...

The convergence of genomics, systems biology, and artificial intelligence is transforming the landscape of drug discovery. Modern genomic technologies now ...

When most people think about science, they conjure images of pipettes, sterile equipment, and people in white lab coats. But ...